Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.
about
Cell- and Gene- Based Therapeutics for Periodontal RegenerationPigment epithelium-derived factor: clinical significance in estrogen-dependent tissues and its potential in cancer therapyPigment epithelium-derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective.Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model.Metastatic osteosarcoma gene expression differs in vitro and in vivoAngiogenesis inhibitors and the need for anti-angiogenic therapeutics.The effects of PEDF on cancer biology: mechanisms of action and therapeutic potentialGene therapy for osteosarcoma: steps towards clinical studies.Chitosan-mediated orally delivered nucleic acids: a gutful of gene therapy.Promising Nanocarriers for PEDF Gene Targeting Delivery to Cervical Cancer Cells Mediated by the Over-expressing FRα.Cancer, chitosan nanoparticles and catalytic nucleic acids.Review: doxorubicin delivery systems based on chitosan for cancer therapy.In vitro and in vivo biological activity of PEDF against a range of tumors.Animal models of osteosarcoma.Pigment epithelium-derived factor as an impending therapeutic agent against vascular epithelial growth factor-driven tumor-angiogenesis.Emerging biotechnological strategies for non-viral antiangiogenic gene therapy.Recent advances in polymeric microspheres for parenteral drug delivery--part 2.Finding chemo: the search for marine-based pharmaceutical drugs active against cancer.Pigment epithelium-derived factor as a natural matrix metalloproteinase inhibitor: a comparison with classical matrix metalloproteinase inhibitors used for cancer treatment.Effective antitumor gene therapy delivered by polyethylenimine-conjugated stearic acid-g-chitosan oligosaccharide micelles.Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis.Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy ratsTranslating chitosan to clinical delivery of nucleic acid-based drugsBiocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity
P2860
Q26774890-0155FA0E-30FC-4D22-A817-72E585363AC5Q26777495-4A54D215-EA17-4B35-B653-94FFF5A06804Q33631541-A5FDEB6F-5C9D-4CB0-AC20-56C7FEA7E348Q35623083-0F8341D9-8B38-42E1-8C0A-9F65F392A3E0Q36803666-E5237C2B-101E-4078-B70B-2DC3DAAD559AQ36949560-843C8727-EED8-4BBC-9AAA-6FF66511502DQ37000498-527A8BE1-DECD-4810-8549-800E399626E2Q37124981-894799D6-EAF6-4111-A26E-600D85232B60Q37150905-D867EC4F-4734-464B-ADA0-6689C734052CQ37220620-61E349E4-A6C9-4C7E-A37B-5F30A12520DAQ37363420-4F758928-7627-4927-B7DC-674D5A90D8D1Q37380142-0A6E3FF0-F9F5-4EF8-AD6E-856AD89A190EQ37634555-E23E10EE-6A74-445F-BAD1-6B118384458CQ37782099-A2E851BC-C78F-4F89-BA6C-9506EF80FC37Q37828119-AE6209DF-A5C2-4BD4-9205-558A9F2557D1Q38034448-321A91F4-1779-400D-AA5D-37ABD49AE17EQ38038244-B5E64473-65B5-480E-B79F-5AB83BA444F9Q38127449-801FBEAF-6FF0-4730-8E8D-5BAA348AA6E9Q38201795-5A0A4AC7-D1B3-4ABA-956C-7A5949910475Q38322009-495A06B5-D3A9-4665-966B-B64702A5215AQ38957716-CF2C5DF2-D64C-4E43-B4FE-6ABB606A71ECQ39231810-A9804727-D5E8-4A48-B06B-5F7279128BA9Q57184027-07D6AC63-3A8B-43A4-A887-90EE28CC714BQ57556362-4169BF6B-BC0C-4A82-BAD5-D153212680F0Q58479013-AFD70ACC-D8F6-465F-936C-BAC1D7C2DA1D
P2860
Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chitosan microparticles encaps ...... astatic model of osteosarcoma.
@en
type
label
Chitosan microparticles encaps ...... astatic model of osteosarcoma.
@en
prefLabel
Chitosan microparticles encaps ...... astatic model of osteosarcoma.
@en
P50
P1433
P1476
Chitosan microparticles encaps ...... tastatic model of osteosarcoma
@en
P2093
Crispin R Dass
Karla G Contreras
P304
P356
10.1016/J.BIOMATERIALS.2007.03.016
P577
2007-03-18T00:00:00Z